Problem statement: Answer the multiple choice question.
Query: Which drug exhibits a 18.958% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a) Cn1cccc1C(=O)NCc1ccc(S(N)(=O)=O)cc1
b) COc1ccc(/C=N/NC(=O)c2cccc(C(=O)N/N=C/c3ccc(OC)cc3)n2)cc1
Answer: b. COc1ccc(/C=N/NC(=O)c2cccc(C(=O)N/N=C/c3ccc(OC)cc3)n2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(/C=N/NC(=O)c2cccc(C(=O)N/N=C/c3ccc(OC)cc3)n2)cc1
COc1ccc(/C=N/NC(=O)c2cccc(C(=O)N/N=C/c3ccc(OC)cc3)n2)cc1
2-N,6-N-bis[(E)-(4-methoxyphenyl)methylideneamino]pyridine-2,6-dicarboxamide